Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cardiotoxicity × 90 days × Clear all

Phase

Phase 2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 321 Neoplasms 295 Prostatic Neoplasms 174 Lung Neoplasms 146 Colorectal Neoplasms 112 Motor Activity 69 Uterine Cervical Neoplasms 65 Carcinoma, Non-Small-Cell Lung 60 Head and Neck Neoplasms 58 Ovarian Neoplasms 49 Brain Neoplasms 48 Pancreatic Neoplasms 41 Colonic Neoplasms 40 Anxiety Disorders 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Neoplasm Metastasis 37 Melanoma 35 Rectal Neoplasms 33 Multiple Myeloma 32 Hematologic Neoplasms 30 Carcinoma, Hepatocellular 30 Stomach Neoplasms 28 Lymphoma 28 Endometrial Neoplasms 28 Pain 27 Leukemia, Myeloid, Acute 27 Glioma 27 Urinary Bladder Neoplasms 26 Depression 26 Sarcoma 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06595147 2026-01-08

BE-FITTER

University of Alberta

Phase NA Recruiting

Breast Neoplasms, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡